Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

ALS (ASX:ALQ) share price jumps on HY21 results

The ALS Ltd (ASX: ALQ) share price jumped nearly 8% today after the company released its HY21 results. Here are the key points.

The ALS Ltd (ASX: ALQ) share price jumped nearly 8% today after the company released its HY21 results.

ALS is one of the world’s largest providers of laboratory testing, inspection, certification and verification solutions.

ALS’ HY21 result

ALS reported an 8.9% fall in revenue, which came in at $838.8 million. The company noted an improvement in the second quarter, with revenue declining 7.8% compared to a 9.7% decline in Q1.

Earnings before interest, tax, depreciation and amortisation (EBITDA) dropped 9.3% to $197.9 million.

The company’s Life Sciences division held up the best on an EBITDA basis, falling 0.2%. EBITDA of the Commodities, Industrial and Other divisions fell 12.7%, 16.4% and 23.6%, respectively.

More positively, cost-cutting and a focus on cash collection resulted in EBITDA margin expansion across the company’s three core divisions of Life Sciences, Commodities and Industrial.

Managing director and CEO Raj Naran commented: “We believe that the first quarter will be our most challenging of FY21 which is reflected in this result as our second quarter has delivered a significant improvement across the Group.”

“We reacted quickly at the beginning of the COVID-19 pandemic to leverage our ‘hub and spoke’ model to align costs with client demand,” he added.

ALS dividend

The ALS board has declared a fully franked interim dividend of 8.5 cents per share (cps). The ex-dividend date is 26 November 2020 and the payment date will be 16 December 2020. The 8.5 cps interim dividend is down 26% from the 11.5 cps interim dividend paid last year.

This represents a payout ratio of 51%, which management believes “reflects the prudent capital management strategy and also demonstrates the Group’s strong liquidity position”.

Buy, hold or sell?

The ALS share price is up more than 50% in the past six months, despite being financially impacted by the COVID-19 pandemic.

I believe the market has already factored in much of ALS’s announced Q2 recovery and that there may be better investment opportunities right now.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned
Skip to content